MEDTOX Scientific, Inc. (MTOX)
The Company provides forensic and clinical laboratory services, and manufactures diagnostic devices in the United States. The company operates in two segments, Laboratory Services and Product Sales.
Recs
Solid co. with high growth potential.
Recs
It has carved out a real nice niche in growth area... is preferred by larger concerns in an arena where being kleenex or xerox goes a long way.
Recs
The past few weeks have fairly well indicated that mtox has hit the bottom and is now climbing from a bumpy 'cup'; the handle needs a bit more time, but for contrarions, I'd say it was a good bet. MTOX is in a terrific market. The risk factor here is the quality of management, but given the strength of this sector in the next several years, I'd bet there's a good margin for error without foiling the mission.
Recs
Halfway from the 52-week high... what do I have to lose?
Recs
Good entry point
Recs
Medtox has been beaten down over the last month about 40%. The financials appear solid, earnings growth is very respectable, and I believe that with a couple more quarters of solid earning growth the stock should begin to pull back nicely.
It is not a time to buy in again yet. I would wait until the market in general has stabilized and a solid base has developed with some upwards momenteum.
Recs
The Company is engaged in distinct but related businesses, which for financial reporting purposes are
divided into two reportable segments: Laboratory Services and Product Sales
Recs
40% again since Nov
Recs
Under HEAVY accumulation by institutional investors... Q1 Earnings up 106%
Recs
Great Industry and attractive price
Recs
a good cap[s and biotech review
Recs
IBD 100 Top 25, 4/14/2007
Recs
Medtox Scientific is a good play on the medical devices side with signficant upside. As the need for workplace testing becomes more sophisticated, advanced devices will be needed for more accurate testing.
Recs
IBD New high list small cap med stock with great earnings. see if this play works
Recs
Profitable on their own with a distinct and growing niche. MTOX will be a buyout target within the next few years.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 15 of 15